Obliterative bronchiolitis, also known as bronchiolitis obliterans or OB, is a direct manifestation of chronic or acute allograft rejection
This contrasts with the authors' existing knowledge that C4d deposition along the peritubular capillaries is a fairly specific marker of Immorally mediated allograft rejection
Molecular heterogeneity in acute renal allograft rejection
identified by DNA microarray profiling.
Chart reviews were performed by investigators blinded to the results of donor DNA measurement to ascertain each patient's posttransplantation course to identify episodes of kidney or pancreas allograft rejection
as determined by standardized histologic grading of biopsies.
The risk of subsequent allograft rejection
is probably low.
Tacrolimus has become an established immunosuppressive agent for the prophylaxis and treatment of renal allograft rejection
Chapters address topics such as chemokine receptors and transplantation, measurement of intracellular cytokines to improve therapeutic monitoring of immunosuppressive drugs following lung transplantation, polyoma BK virus nephropathy in renal transplant recipients, immunobiology of xenograft rejection, and the role of viruses in allograft rejection
Recent data from the Lung Allograft Rejection
Gene expression Observational (LARGO) study provides compelling evidence that profiling gene expression in peripheral blood can detect organ rejection in lung transplant patients.
Tacrolimus (FK 506) is a potent macrolide immunosuppressive agent that has been used as a primary immunosuppressant for the prevention of allograft rejection
Comparison of histopathology in acute allograft rejection
and recurrent hepatitis C infection after liver transplantation.
antigen presenting cells) to block the second signal necessary to activate T cells, which are the predominate immune mediators of allograft rejection
The European Commission approved Advagraf(R) on April 23, 2007 for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and for the treatment of allograft rejection
resistant to treatment with other immunosuppressive drugs in adult patients in Europe.